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Auditory Brainstem Implants were developed to partially 
restore the hearing capabilities of patients without cochlear 
nerves bilaterally. Aim: this paper aims to discuss the clinical 
and surgical findings of four ABI patients. Materials and 
method: four patients diagnosed with bilateral schwannomas 
received auditory brainstem implants (ABI) and had one 
of their tumors resected in the same surgical procedure. 
Clinical aspects, surgical technique, anatomic landmarks, and 
outcomes were analyzed. Results: the anatomic landmarks 
were identified in all four patients in relation to the foramina 
of Luschka. Two patients had CSF leaks. The electrodes were 
well positioned and hearing sensation was good enough to 
allow for sound recognition and assist patients perform lip 
reading. Conclusion: the outcomes observed in our patients 
were quite encouraging and offer great perspectives for those 
suffering from deep bilateral deafness and impaired central 
auditory pathways.
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INTRODUCTION
Auditory Brainstem Implants were developed to 
partially restore the hearing capabilities of patients without 
cochlear nerves bilaterally1. They were first developed as a 
one-channel electrode at the House Ear Institute (HEI), in 
Los Angeles, California. This first model was implanted in 
25 patients between 1979 and 1992, producing precarious 
clinical results2. A multichannel device was then developed 
from this experience by HEI in partnership with the Co-
chlear Corporation (Englewood, Colorado) and the Hun-
tington Medical Research Institute (Pasadena, California). 
The device was made up by an internal unit containing a 
silicone cable with disc-shaped platinum electrodes and 
an interface to a Nucleus Mini-22 speech processor.
Patients classically benefitting from this electronic, 
surgically-implanted hearing aid are those diagnosed 
with neurofibromatosis type 2 (NF-2), bilateral vestibular 
schwannomas, and children with cochlear nerve conge-
nital aplasia. Today the indication for auditory brainstem 
implants has been extended to patients with damaged VIII 
nerves and those who are ineligible for conventional coch-
lear implants such as post-meningitis patients with ossified 
cochleas3,4. Although the first implantation procedure dates 
back from 1979, only in October of 2000 was it approved 
for clinical use by the Food and Drug Administration.
OBJECTIVES
This paper aims to discuss the clinical and surgical 
findings pertaining to the first four ABI patients treated 
in our institution, looking at indication criteria, surgical 
technique, and outcomes.
MATERIALS AND METHOD
Four patients diagnosed with bilateral vestibular 
schwannomas received auditory brainstem implants (ABI) 
and had one of their tumors resected in the same surgi-
cal procedure. This study was approved by the medical 
ethics committee at our institution under permit M.16-
196/2007.
The translabyrinthine approach was chosen to re-
move the tumors and expose the cochlear nerve on the 
lateral wall of the IV ventricle (foramina of Luschka). Each 
patient was implanted one Cochlear N24® ABI internal 
unit. The VII, IX, X and XI nerves were monitored through 
continuous electrophysiology during surgery. Electric res-
ponse brainstem audiometry was used to check whether 
the electrodes had been properly put in place.
Free field audiometry tests were conducted to check 
patient hearing after three months of activation.
Patient, surgery, and external unit activation data 
can be seen on Table 1. Figures 1 to 4 show X-ray images 
of the removed tumors.
Table 1. Patients, surgery, and external unit activation data.
Patient Age Gender Diagnosis Tumor Size Surgery Date Activation Date
1 28 M NF2 3,5 cm Jan 2006 Feb 2006
2 25 F NF2 IC Mar 2006 Apr 2006
3 25 M NF2 4.0 cm Mar 2006 Apr 2006
4 26 M NF2 2.0 cm Dec 2006 Jan 2007
Figure 1. MRI (T1 contrast-enhanced) case 1 preoperative axial 
view.
RESULTS
The classic translabyrinthine approach was sa-
tisfactorily used to remove the tumors and identify the 
foramina of Luschka. The anatomic landmarks in relation 
to the foramina, namely the IX nerve and the cerebellar 
floculus, were successfully accessed by the surgeon by 
completely uncovering the jugular bulb from the bony 
layer that wraps it and completely exposing the entire dura 
from the middle and posterior cerebral fossae. The dura in 
the posterior fossa was broadly opened. The incision had 
borders close to the jugular bulb, the sigmoid sinus, and 
the upper petrous sinus. All procedures were uneventfully 
completed, and the electrodes were positioned touching 
the cochlear nucleus on the lateral wall of the IV ventricle. 
Cerebrospinal fluid leaks occurred in patients 2 and 3. 
They were treated with lumbar punction (patient 3) and 
obliteration surgery using abdominal fat (patient 2).
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Activation was carried out on average at 30 days 
after surgery, with the patients in a surgical setting with 
cardiac monitoring. Except for patient 1, who experienced 
sound sensation in only one electrode, all others made 
reference to hearing sensation in more than 12 electrodes. 
Side effects were observed in 88% of the upper, lower 
limbs, and abdomens and in 12% of all heads and necks 
(throat and nausea). Graph 1 shows the hearing outcomes 
as observed in tone free field audiometry tests carried out 
three months after activation.
Figure 3. MRI (T1 contrast-enhanced) case 3 preoperative axial 
view.
Figure 4. MRI (T1 contrast-enhanced) case 4 preoperative axial 
view.
Figure 2. MRI (T1 contrast-enhanced) case 2 preoperative axial 
view.
Graph 1. Hearing thresholds of ABI patients three months after ac-
tivation
DISCUSSION
The concepts related to auditory brainstem implants 
are similar to those applicable to the currently available 
cochlear implants, except for the electrode setup which, 
in the first case, is designed to be introduced at the level 
of the cochlear nerve and not at the cochlear tympanic 
ramp. Patients who for functional or anatomic reasons 
are unable to receive electric stimuli in their inner ears 
are the best candidates for this treatment. In more socially 
advanced countries, the main cause of bilateral structural 
loss of peripheral auditory pathways is neurofibromatosis 
type 2, a condition that typically evolves into bilateral 
vestibular schwannomas5. That however is not the case 
for Brazil. Infection is still the main etiology for deafness, 
meningitis certainly being the main culprit6. Some 23.9% 
of all cochlear implant patients experienced hearing loss 
following meningitis. This is a reason for great concern, 
once the hearing prognosis after implantation is closely 
connected to the number of viable neural elements and 
the accurate positioning of the electrodes in the cochlea. 
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And meningitis goes against both factors. Firstly, it is the 
etiology that most destroys cochlear hair cells and coch-
lear nerve neurons; secondly, it will often lead to some 
degree of ossification in the otic capsule. Apart from the 
functional involvement, meningitis was also responsible 
for all six cases of failed electrode positioning during sur-
gery, with consequent removal of the internal unit and a 
second procedure to implant new electrodes. This infection 
only comes to greatly increase the need for an alternative 
to conventional cochlear implants in Brazil. Neurofibro-
matosis type 2 patients are rare, even at reference care 
centers. Nonetheless, when taking into account the tragic, 
progressive slow evolution of this disease, the impact for 
the patients of having some of his or her hearing restored 
is extremely relevant.
In our few first cases, we tried to perform surgery 
on patients with the so-called classic indication for both 
tumor removal and electrode implantation. Patient 1 was 
first selected for having extensive knowledge on the proce-
dure, as he has for years informally studied NF2 and gone 
through a number of surgical procedures previously. Full 
awareness of the possibilities and limitations of the pro-
posed procedure is a key factor in fine-tuning the patients’ 
expectations and consequent post-operative satisfaction. 
Both patients and their families must be well-informed of 
the natural history of NF2, the surgical procedure itself, and 
of the possibility of there being partial hearing restoration 
after implantation. Patients and families go through a rigo-
rous psychological and social evaluation, not to mention 
medical and audiological screening.
There are two main approaches for auditory brains-
tem implant placement: suboccipital retrosigmoid and 
translabyrinthine7. The elected approach should provide 
for ample enough visualization to allow for the precise 
identification of the anatomic landmarks used as refe-
rence for accurate electrode placement. Surgeons base 
their choice on their own personal experience. Most ENT 
surgeons pick the translabyrinthine approach to remove 
large vestibular schwannomas or when treating patients 
with deteriorated hearing. As tumors had to be removed 
and electrodes implanted on one same surgical procedure, 
this was the approach we chose. The surgical technique 
used to place the electrodes is similar to the one used to 
remove vestibular schwannomas. The cochlear nucleus 
complex, made up by the ventral and dorsal cochlear 
nuclei, is the site for electrode placement. The ventral 
cochlear nucleus is the main nucleus for neural impulse 
transmission from the VIII nerve, and its axons form the 
main ascending pathway of the cochlear nerve. Neither 
the ventral nor the dorsal nucleus can be seen during 
surgery, and their location can only be inferred from the 
identification of anatomic landmarks adjacent to them. The 
lateral end of the IV ventricle, the foramina of Luschka, is 
located between the outputs of the glossopharyngeal and 
facial nerves. As the floculus is moved away, the surgeon 
can visualize a depression between the above mentioned 
cranial nerves, which is the site where the electrode is to 
be inserted. Usually only one stump of the cochlear nerve 
can be identified. It may also be used as a landmark for the 
lateral recess. One should bear in mind that the removal 
of large tumors often introduces changes to the anatomy 
of the area, mainly in relation to the emergence of the 
VIII nerve from the pons which becomes hard to identify 
as the integrity of the nerve is lost during surgery and re-
mains of the arachnoid are still present. Observation of the 
anatomically preserved structures, besides the distal and 
proximal tumor site, and intraoperative electromyography 
are undoubtedly useful parameters during electrode place-
ment. In our four cases the anatomic landmarks were well 
preserved, as seen mainly in the first two patients whose 
tumors were smaller. Patient 1 had a small tumor that did 
not project itself into the posterior cerebral fossa, thus 
leaving the surface of the brainstem intact and, therefore, 
with easily identifiable landmarks. The main landmarks for 
patient 2 were the bulb cranial nerves and the cerebellar 
floculus, with a well-preserved foramina of Luschka.
Patient 2 had bilateral intracanal lesion and recent 
deep dysacusis, turning her into an excellent candidate 
for the first case, both from the surgical standpoint, as the 
anatomic landmarks for the foramina of Luschka would not 
be deformed by the tumor, and for her improved hearing 
prognosis due to the recent onset of sensorial deprivation. 
Although this analysis stood correct, the patient evolved 
to a rather uncommon condition after surgery, as she 
had a CSF leak that did not respond to a lumbar shunt. 
She thus had to be operated again to surgically close the 
fistula. Her routine CSF test showed tumor cells further 
described by the pathologist as coming from a choroid 
plexus papilloma. The aggressive evolution of the tumor 
and the consequent need for chemotherapy and radio-
therapy led the patient to stop using the implant during 
treatment. Today the patient is stable and clinically well, 
and went back to using the implant daily. Metastasis in 
the inner ear meatus is rarely observed, and seldom can 
it be radiologically differentiated from small vestibular 
schwannomas. This rare differential diagnosis is something 
we should all have in mind, as one of the approaches for 
small ear tumors is clinical follow-up.
Patients 3 and 4 had larger tumors, thus making it 
harder to identify the foramina of Luschka as anatomic 
changes were present in the area. Once it was found, the 
electrodes could be well positioned in both cases.
The hearing outcomes for all four patients were 
quite encouraging. In our sample, the presence of hearing 
thresholds corresponding to mild hearing loss and even 
normal thresholds in some frequencies suggest the patients 
were able to perceive many sounds in the environment, 
including high frequencies, showing that the ability to 
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perceive environment sounds and perform speech recog-
nition assisted by lip reading can be restored with this 
type of implant8,9. Although the outcomes provided by 
the auditory brainstem implants were compared against 
those of one-channel cochlear implants10, the early free 
field audiometry test results were positively surprising, 
mainly in terms of patient compliance and daily use of 
the hearing aid.
CONCLUSION
In spite of the early-stage results gathered, we be-
lieve the outcomes observed in our patients were quite 
encouraging and offer great perspectives for those suffe-
ring from deep bilateral deafness and impaired central 
auditory pathways.
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